Home
About
FAQ
History (6)
Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.
Khanna, Omaditya
Partnering With Schools for Community-Based Health Interventions: How Educating Children Improves Hypertension Awareness.
Shegog, Jamehl
Low recurrence of instability and satisfying patient-reported outcomes following various surgical treatments of reverse Hill Sachs lesions in the setting of posterior instability: a systematic review.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (69)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Michael D. Chan MD
Wake Forest School of Medicine
Why?
Michael K. Farris MD
Wake Forest School of Medicine
Why?
Christina K. Cramer MD
Wake Forest School of Medicine
Why?
Stephen R. Rapp PhD
Wake Forest School of Medicine
Why?
Ryan T. Hughes MD
Wake Forest School of Medicine
Why?
Stephen B. Tatter MD, PhD
Wake Forest School of Medicine
Why?
Jimmy Ruiz MD
Wake Forest School of Medicine
Why?
J. M. Cline DVM, PhD
Wake Forest School of Medicine
Why?
Adrian W. Laxton MD
Wake Forest School of Medicine
Why?
Kounosuke Watabe PhD
Wake Forest School of Medicine
Why?
Fang-Chi Hsu PhD
Wake Forest School of Medicine
Why?
John D. Bourland PhD
Wake Forest School of Medicine
Why?
Heather D. Pacholke MD
Wake Forest School of Medicine
Why?
Debra I. Diz PhD
Wake Forest School of Medicine
Why?
Thomas W. Lycan DO, MHS
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 5
Next
Prev
Search Criteria
Cranial Irradiation
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions